EU begins real-time review of AstraZeneca COVID-19 antibody cocktail

Published by

(Reuters) – The European Union’s medicines regulator said on Thursday it has started a real-time review of AstraZeneca’s antibody-based COVID-19 therapy after the combination medicine showed success in treating and preventing severe illness. (Reporting by Pushkala Aripaka in Bengaluru; Editing by Arun Koyyur)

Read More

Leave a Reply

Your email address will not be published. Required fields are marked *